Stockreport

Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF Achieved record quarterly and full-year total revenue of $86 million and $292 million, respectivelyProvides full year 2026 total revenue guidance range of $375 million t [Read more]